New research shows baricitinib could be an effective treatment option for patients with atopic dermatitis who do not respond to dupilumab. A team, led by Linde de Wijs, Department of Dermatology, Erasmus MC University Medical Center, evaluated the effectiveness and safety of baricitinib treatment in daily practice for patients with atopic dermatitis who have inadequately responded […]